Biovica’s DiviTum technology selected for new cancer drug trial
Biovica’s DiviTum technology has been selected by the International Breast Cancer Study Group (IBCSG, Bern) and the Breast International Group (BIG, Brussels) to be part of a state of…
Read More...
Read More...